Peptide library › Brain & nerves
Trofinetide
Also known as Daybue, NNZ-2566
First approved treatment for Rett syndrome, a rare genetic brain condition; taken by mouth as a liquid.
What people use it for
- Rett syndrome in adults and children aged 2 and over
What Trofinetide does in the body
A modified version of a small fragment of IGF-1 (glypromate). It's thought to reduce brain inflammation and support connections between nerve cells.
Strength of evidence
Moderate: the Phase 3 LAVENDER trial showed modest improvements in symptoms.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Diarrhoea, very common and sometimes severe
- Vomiting
- Weight loss
Who should avoid it or take extra care
- Moderate to severe kidney impairment
- Dehydration risk needs monitoring
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2023 as Daybue. Prescription only.
How it's taken
Route: Liquid by mouth or through a feeding tube, twice daily
How long it lasts (half-life): About 1.5 hours
Latest research & news
- Clinically Meaningful Response on the Rett Syndrome Behavior Questionnaire: A Responder Analysis of Patients Treated with Trofinetide Versus Placebo in the 12-Week LAVENDER Trial
Research · Study · PubMed · J Child Adolesc Psychopharmacol · 19 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Trofinetide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Trofinetide in Fiala How to installMore in Brain & nerves
- NNZ-2591Experimental oral medicine studied for rare genetic brain conditions such as Phelan-McDermid and Angelman syndromes.
- DavunetideExperimental nasal-spray peptide studied to protect brain cells, mainly in progressive supranuclear palsy.
- ZiconotideNon-opioid painkiller made from cone snail venom, given by a pump into the spinal fluid for severe chronic pain.